Search Results
13 items found for "David Allard"
- Ep 118 with Dr. David Sykes
David Sykes About Dr. David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD David has over 20+ years of experience working in a drug discovery environment mainly in a specialist In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology David Sykes on the web Veprintsev Lab ResearchGate LinkedIn Dr.
- Ep 33 with Dr. David E. Gloriam
David E. Gloriam About this episode David Gloriam is a Professor in Computational Receptor Biology at the University David obtained his Ph.D. from Uppsala University in Sweden where he worked on the bioinformatic identification Join me a learn more about David’s work, his career trajectory, and GPCRdb. Dr. David E.
- Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Authors Karthik Nath, Tala Shekarkhand, David Nemirovsky, Andriy Derkach, Bruno Almeida Costa, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David J Chung, Heather J Landau, Oscar B Lahoud, Michael Scordo
- Ep 124 with Gáspár Pándy-Szekeres
Gáspár Pándy-Szekeres " After a BSc in biology and a MSc in bioinformatics, I have been working in David
- Ep 52 with Dr. Benjamin Myers
Prior to that, Ben received his Ph.D. from UCSF in 2008, where he worked with David Julius on the structure
- Ep 100 with Dr Caron Tribute Part 1
David Sibley (1988) Memories our panelists shared with us Thanks for listening to this podcast episode
- GprC of the nematode-trapping fungus Arthrobotrys flagrans activates mitochondria and reprograms fungal cells for nematode hunting
Authors Xiaodi Hu, David S Hoffmann, Mai Wang, Lars Schuhmacher, Maria C Stroe, Birgit Schreckenberger
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
Authors Mor Oron-Herman , David Kirmayer , Amelie Lupp , Stefan Schulz , Genady Kostenich , Michel Afargan
- Dr. GPCR Summit 2021 Live Talks
David Gloriam, Dr. David Gloriam September 15, 2021 at 6:00:00 PM Learn More >> Hydroxycarboxylic acid receptor 3 and GPR84
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
To determine GPR68 inhibition's mechanism of cell death we use DAVID pathway analysis of RNAseq.
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
Authors Brian Kim , Marc E Rothenberg , Xin Sun , Claus Bachert , David Artis , Raza Zaheer , Yamo Deniz
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
About Yimin Zou "I received Ph.D from University of California at Davis and San Diego in 1995 and then Mosharov1,2,4, David Sulzer1,2,4, Christoph Kellendonk1,2, and Jonathan A.
- Ep 146 with Dr Michael Feigin
David Tuveson at CSHL where he participated in the development of an organoid system for the culture